10

Molecular Formula : C10 H12 N2 . Cl H

Molecular Formula : C14 H11 N O5

Molecular Formula : C14H7D4NO5

Molecular Formula : C27H26ClNO8

Molecular Formula : 13C6 C8 H12 Cl N O2

Molecular Formula : C15 H14 N O3 . Na . 2 H2 O

Molecular Formula : C15 D3 H12 N O3

Molecular Formula : C15 H15 N O3

Molecular Formula : C16 2H10 H13 N O . Cl H

Molecular Formula : C16 H14 F3 N O3 S

Molecular Formula : C18 2H3 H11 F3 N3 O4 S

Molecular Formula : 2 C9 H6 N2 O2

Toluene-d8, 99.6 Atom Percent D

Toluidine Blue O

Molecular Formula : C17 H13 N3 O3

Molecular Formula : C13 H14 N2 O3

Molecular Formula : C10H6D7Cl2FN2O2S2

Molecular Formula : C27 H45 N O2 . Cl H

Molecular Formula : C50 H83 N O21

Molecular Formula : C18 D11 H15 O

Molecular Formula : C30 H38 O11

Molecular Formula : C25 H40 N2 O14 S

Molecular Formula : 13C6 C6 H21 N O8 S

Molecular Formula : C12 2H12 H9 N O8 S

Molecular Formula : C23 D6 H18 N3 Na O6

Molecular Formula : C26H25F9N2O4

Molecular Formula : C35 H28 F3 N5 O2

Molecular Formula : C16 H20 N4 O3 S

Molecular Formula : C16 2H7 H13 N4 O3 S

Molecular Formula : C19 H15 F3 N4 O3 . C7 H8 O3 S . H2O

Molecular Formula : C7 H16 N2

Molecular Formula : C10 H13 N O4 S

Total Ionic Strength Adjustment Buffer, Solution, For Fluoride, APHA

GenScript supplies 2.5 ml endotoxin-free tubes with plain
end made of research-grade glass. GenScript′s Endotoxin-free tubes can be
applied to dilute or aliquot sample with an especial requirement of endotoxin
level (< 0.005 EU/ml). GenScript Endotoxin-free tubes
are provided in encapsulation with pyrogen-free aluminum foil (folded into a
package), which sufficiently inhibits the introduction of any contamination,
such as RNase/DNase. 

Molecular Formula : C12H13N5O4

Molecular Formula : C12 H10 F N3 O2 S

Thrombopoietin (TPO) is a glycoprotein hormone which belongs to the EPO/TPO family. It produced by the liver and kidney which regulates the production of platelets. TPO stimulates the production and differentiation of megakaryocytes, the bone marrow cells that bud off large numbers of platelets. Lineage-specific cytokine affects the proliferation and maturation of megakaryocytes from their committed progenitor cells. It acts at a late stage of megakaryocyte development. It may be the major physiological regulator of circulating platelets.

Thrombopoietin (TPO), also known as C-mpl ligand, MGDF and Thpo, is a glycoprotein hormone belonging to the EPO/TPO family. It is expressed mainly in the liver, kidney and skeletal muscle. TPO binds and signals through MLP/C_MPL receptor. It stimulates the proliferation and maturation of megakaryocytes from their committed progenitor cells, and it regulates the production and circulation of platelets. TPO has also been reported to promote the apoptosis of hypoxia-sensitized neurons and to inhibit neuronal differentiation.

Molecular Formula : C39H43N3O11S

TNF-related apoptosis-inducing ligand (TRAIL), also known as Tumor Necrosis Factor Super-Family 10 (TNFSF10) or apoptosis 2 ligand (Apo2L), is a pleiotropic cytokine thatbelongs to the TNF superfamily. Full length TRAIL expressed in vivo is a type II transmembrane protein, although the soluble form also exists and functions. TRAIL has four major receptors: two death receptors DR4 and DR5, and two decoy receptors DcR1 and DcR2. TRAIL binds to the death receptors which recruits the FAS-associated death domain and activates caspases 8 and 10 which eventually leads to apoptosis. Because of its antitumor potential, TRAIL is activelystudied as a therapeutic agent. On the other hand, abnormal expression of TRAIL in small arteries can induce the proliferation of smooth muscle cells, thereby increasing vascular remodeling and pulmonary arterial hypertension.

TRAIL/Apo2L, also known as Tumor Necrosis Factor Super-Family 10 (TNFSF10), is a pleiotropic cytokine thatbelongs to the TNF superfamily. The full length TRAIL expressed in vivo is a Type II transmembrane protein, although the soluble form also exists and functions. TRAIL has four major receptors: two death receptors DR4 and DR5, two decoy receptors DcR1 and DcR2. TRAIL binds to the death receptors, recruits the FAS-associated death domain, activates caspases 8 and 10, and eventually leads to apoptosis. Because of its antitumor potential, TRAIL is actively studied as a therapeutic agent. On the other hand, abnormal expression of TRAIL in small arteries can induce the proliferation of smooth muscle cells, resulting in increasing vascular remodeling and pulmonary arterial hypertension.

Molecular Formula : C22H14D5Br4NO3